However, the NCCN also considers a subset of patients who are classified as very low-risk in the presence of a prostate-specific antigen (PSA) density (PSAD) < 0.15 ng/mL/cc and less than three biopsy-positive cores with cancer involving no more than 50% of each invaded core [3]. Here, KLK3 is linked to cancer.